Writing the summary…
One CRISPR treatment cut “bad” cholesterol in half for a full year
Source: Science Daily
Original reporting
Science Daily: read the full reportRelated stories
Science Daily
Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression
A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia. Lab experiments suggest the popular joint supplement may intensify an abnormal sugar-tagging process in the Alzheimer’s brain, although researchers say clinical trials are needed to determine whether it actually causes harm.
BBC Science
Your pictures of the Harvest Moon shimmering across the UK sky
The full Moon put on a stunning display over the skies of UK on Saturday night and here are some of your photographs.
Science Daily
New soil test could reveal how soil microbes help feed plants
Scientists have streamlined a method for measuring DNA-bound phosphorus in soil, making it cheaper and easier while preserving its accuracy. The technique could reveal how soil microbes help recycle phosphorus and ultimately support more sustainable fertilizer and nutrient management.
Science Daily
1.7-billion-year-old fossils reveal a crucial clue to the rise of complex life
Scientists studying ancient Australian rocks uncovered more than 12,000 fossils from some of the oldest known eukaryotes on Earth. These early complex cells lived in settings ranging from coastal mudflats to the open sea, but only where oxygen was available. Oxygen-free environments contained simpler microbes instead. The findings strengthen the idea that oxygen played a crucial role in the emergence of complex life.
NPR Health
From professor to patient: One man's journey on the frontier of lung cancer treatment
Lung cancer is still the top cancer killer, but new developments are shifting what the future might hold for patients.
Science Daily
Why rheumatoid arthritis pain may persist even when inflammation is under control
Pain and fatigue in rheumatoid arthritis can persist even after inflammation improves, with depression, poor sleep, obesity, smoking, and chronic pain potentially helping sustain symptoms. Researchers say identifying these hidden drivers could prevent unnecessary medication changes and lead to more personalized treatment.